References - Therapeutic Strategies in Cancer Biology and Pathology - page 207

Dong, S., Kang, K., Gu, T., Kardar, S., Fu, H., Lonial, S., et al., 2007b. 14-3-3 integrates pro-
survival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1 trans-
formed hematopoietic cells. Blood 110, 360-369.
Dong, S., Kang, S., Lonial, S., Khoury, H.J., Viallet, J., Chen, J., 2008. Targeting 14-3-3 sensi-
tizes native and mutant BCR-ABL to inhibition with U0126, rapamycin and Bcl-2 inhibi-
tor GX15-070. Leukaemia 22, 572-577.
Dorman, D., Wertz, I., Shimizu, H., Arnott, D., Frantz, G.D., Dowd, P., et al., 2004. The ubiq-
uitin ligase COP1 is a critical negative regulator of p53. Nature 429, 86-92.
Dorrello, N.V., Peschiaroli, A., Guardavaccaro, D., Colburn, N.H., Sherman, N.E., Pagano,
M., 2006. S6K1- and beta TRCP-mediated degradation of PDCD4 promotes protein
translation and cell growth. Science 314, 467-471.
Douglas, A.E., Heim, J.A., Shen, F., Almada, L.L., Riobo, N.A., Fernandez-Zapico,
M.E., et al., 2011. The alpha subunit of the G protein G(13) regulates activity of one
or more Gli transcription factors independently of Smoothened. J. Biol. Chem. 286,
30714-30722.
Dovey, J.S., Zacharek, S.J., Kim, C.F., Lees, J.A., 2008. Bmi1 is critical for lung tumo-
rigenesis and bronchioalveolar stem cell expansion. Proc. Natl. Acad. Sci. U.S.A. 105,
11857-11862.
Dowling, R.J., Goodwin, P.J., Stambolic, V., 2011. Understanding the benefit of metformin
use in cancer treatment. BMC Medicine 9, art. no. 33.
Du, H., Yao, W., Fang, M., Wu, D., 2011. ARF triggers cell G1 arrest by a P53 independent
ERK pathway. Mol. Cell. Biochem. 357, 415-422.
Du, R., Sun, W., Xia, L., Zhao, A., Yu, Y., Zhao, L., et al., 2012. Hypoxia-induced down-
regulation of microRNA-34a promotes EMT by targeting the notch signaling pathway in
tubular epithelial cells. PLoS ONE 7, e30771.
Dubois, T., Rommel, C., Howell, S., Steinhussen, U., Soneji, Y., Morrice, N., et al., 1997. 14-
3-3 is phosphorylated by casein kinase I on residue 233. Phosphorylation at this site in
vivo regulates Raf/14-3-3 interaction. J. Biol. Chem. 272, 28882-28888.
Duchaine, T.F., Wohlschlegel, J.A., Kennedy, S., Bei, Y., Conte Jr, D., Pang, K., et al., 2006.
Functional proteomics reveals the biochemical niche of C. elegans DCR-1 in multiple
small-RNA-mediated pathways. Cell 124, 343-354.
Duesbery, N.S., Webb, C.P., Leppla, S.H., Gordon, V.M., Klimpel, K.R., Copeland, T.D.,
et al., 1998. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.
Science 280, 734-737.
Dugas, J.C., Cuellar, T.L., Scholze, A., Ason, B., Ibrahim, A., Emery, B., et al., 2010. Dicer1
and miR-219 are required for normal oligodendrocyte differentiation and myelination.
Neuron 65, 597-611.
Durkin, M.E., Ullmannova, V., Guan, M., Popescu, N.C., 2007. Deleted in liver cancer 3
(DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits
tumor cell growth. Oncogene 26, 4580-4589.
Efeyan, A., Sabatini, D.M., 2010. mTOR and cancer: many loops in one pathway. Curr. Opin.
Cell. Biol. 22, 169-176.
Eggers, H., Steffens, S., Grosshennig, A., Becker, J.U., Hennenlotter, J., Stenzl, A., et al. 2012.
Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island
methylation in renal cell carcinoma. Int. J. Oncol. 40, 1650-1658.
El-Kalla, M., Onyskiw, C., Baksh, S., 2010. Functional importance of RASSF1A microtubule
localization and polymorphisms. Oncogene 29, 5729-5740.
El-Masry, O.S., Brown, B.L., Dobson, P.R.M., 2012. Effects of activation of AMPK on human
breast cancer cell lines with different genetic backgrounds. Oncol. Lett. 3, 224-228.